Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.
Miyashita
T
T
Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.
Enosawa
S
S
Suzuki
S
S
Tamura
A
A
Tanaka
H
H
Amemiya
H
H
Matsumura
T
T
Omasa
T
T
Suga
K
K
Aoki
T
T
Koyanagi
Y
Y
D000818:Animals; D019149:Bioreactors; D001794:Blood Pressure; D018929:Cell Culture Techniques / Q000379:methods; D004867:Equipment Design; D005974:Glutamate-Ammonia Ligase / Q000235:genetics / Q000378:metabolism*; D006339:Heart Rate; D018197:Hepatoblastoma; D022781:Hepatocytes / Q000166:cytology / Q000378:metabolism; D006801:Humans; D007427:Intracranial Pressure; D007511:Ischemia; D008099:Liver / Q000098:blood supply; D017093:Liver Failure / Q000628:therapy*; D008113:Liver Neoplasms; D019164:Liver, Artificial; D011994:Recombinant Proteins / Q000378:metabolism; D013552:Swine; D014407:Tumor Cells, Cultured
D011994:Recombinant Proteins; D005974:Glutamate-Ammonia Ligase